These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35140709)

  • 1. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.
    Nguyen HO; Schioppa T; Tiberio L; Facchinetti F; Villetti G; Civelli M; Del Prete A; Sozio F; Gaudenzi C; Passari M; Barbazza I; Sozzani S; Salvi V; Bosisio D
    Front Immunol; 2021; 12():797390. PubMed ID: 35140709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
    Nguyen HO; Salvi V; Tiberio L; Facchinetti F; Govoni M; Villetti G; Civelli M; Barbazza I; Gaudenzi C; Passari M; Schioppa T; Sozio F; Del Prete A; Sozzani S; Bosisio D
    J Transl Med; 2022 May; 20(1):203. PubMed ID: 35538539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells.
    Gianello V; Salvi V; Parola C; Moretto N; Facchinetti F; Civelli M; Villetti G; Bosisio D; Sozzani S
    Biochem Pharmacol; 2019 May; 163():371-380. PubMed ID: 30851246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases.
    Nguyen HO; Tiberio L; Facchinetti F; Ripari G; Violi V; Villetti G; Salvi V; Bosisio D
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils.
    Schioppa T; Nguyen HO; Salvi V; Maugeri N; Facchinetti F; Villetti G; Civelli M; Gaudenzi C; Passari M; Sozio F; Barbazza I; Tamassia N; Cassatella MA; Del Prete A; Bosisio D; Tiberio L
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
    Facchinetti F; Civelli M; Singh D; Papi A; Emirova A; Govoni M
    Front Pharmacol; 2021; 12():740803. PubMed ID: 34887752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
    Heystek HC; Thierry AC; Soulard P; Moulon C
    Int Immunol; 2003 Jul; 15(7):827-35. PubMed ID: 12807821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10.
    Bros M; Montermann E; Cholaszczyńska A; Reske-Kunz AB
    Int Immunopharmacol; 2016 Jun; 35():174-184. PubMed ID: 27070502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection.
    Wiethe C; Debus A; Mohrs M; Steinkasserer A; Lutz M; Gessner A
    J Immunol; 2008 Apr; 180(7):4371-81. PubMed ID: 18354157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.
    Khasawneh A; Baráth S; Medgyesi B; Béke G; Dajnoki Z; Gáspár K; Jenei A; Pogácsás L; Pázmándi K; Gaál J; Bácsi A; Szegedi A; Kapitány A
    Immunol Lett; 2017 Sep; 189():109-113. PubMed ID: 28414181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
    López-Bravo M; Minguito de la Escalera M; Domínguez PM; González-Cintado L; del Fresno C; Martín P; Martínez del Hoyo G; Ardavín C
    J Allergy Clin Immunol; 2013 Dec; 132(6):1409-19. PubMed ID: 24139608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.
    Faries MB; Bedrosian I; Xu S; Koski G; Roros JG; Moise MA; Nguyen HQ; Engels FH; Cohen PA; Czerniecki BJ
    Blood; 2001 Oct; 98(8):2489-97. PubMed ID: 11588047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients.
    Lea S; Metryka A; Li J; Higham A; Bridgewood C; Villetti G; Civelli M; Facchinetti F; Singh D
    Cytokine; 2019 Nov; 123():154739. PubMed ID: 31319374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-Associated ssRNAs Activate Human Neutrophils in a TLR8-Dependent Fashion.
    Gardiman E; Bianchetto-Aguilera F; Gasperini S; Tiberio L; Scandola M; Lotti V; Gibellini D; Salvi V; Bosisio D; Cassatella MA; Tamassia N
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
    Wang Y; Da'Dara AA; Thomas PG; Harn DA
    Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP1981c, a Putative Nucleic Acid-Binding Protein, Produced by
    Kim WS; Shin MK; Shin SJ
    Front Cell Infect Microbiol; 2018; 8():206. PubMed ID: 29977867
    [No Abstract]   [Full Text] [Related]  

  • 20. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
    Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.